Gerhardt, N., Schreiner, R., Thomann, A. K., & Findeisen, P. (2020). Development of a mass spectrometry-based method for quantification of Ustekinumab in serum specimens. Therapeutic drug monitoring, 42(4), . https://doi.org/10.1097/FTD.0000000000000734
Cita Chicago Style (17a ed.)Gerhardt, Nina, Rupert Schreiner, Anne K. Thomann, y Peter Findeisen. "Development of a Mass Spectrometry-based Method for Quantification of Ustekinumab in Serum Specimens." Therapeutic Drug Monitoring 42, no. 4 (2020). https://doi.org/10.1097/FTD.0000000000000734.
Cita MLA (9a ed.)Gerhardt, Nina, et al. "Development of a Mass Spectrometry-based Method for Quantification of Ustekinumab in Serum Specimens." Therapeutic Drug Monitoring, vol. 42, no. 4, 2020, https://doi.org/10.1097/FTD.0000000000000734.